The Vinehealth Cancer Platform receives medical device CE mark certification

"Vinehealth, a UK digital health tech company has received a Class 1 Medical Device CE mark for its Vinehealth Cancer Companion mobile application for patients and VinehealthPRO web application for clinicians.

Vinehealth conforms to the requirements of the Medical Devices Directive 93/42/EEC. The Directive outlines safety and performance requirements for medical devices in the UK & EU.

Vinehealth’s platform combines behavioural science and artificial intelligence to increase the quality of life of cancer patients. The Vinehealth mobile app allows cancer patients to track, manage and understand their care, supporting them to feel in control and better self-manage. The VinehealthPRO web application is used by healthcare professionals to support clinical decision making and inform the development of cancer therapeutics within clinical trials.

This is a momentous achievement for Vinehealth, who after only 2 years of being founded, continue to make waves throughout the digital healthcare industry. The CE mark will enable Vinehealth to enhance the features in both their applications and deliver value to patients, healthcare professionals and life science partners alike.

The team worked tirelessly over a 6 month period, Ravi Khiroya Vinehealth’s Product Owner commented, “I am immensely proud of the whole team's contributions towards achieving our Class 1 CE mark. It has been challenging but we have learnt so much - a testament to our commitment to delivering the best possible product to our users and ensuring their welfare is our highest priority”..." Lire la suite